Department of the Army December 20, 2013 – Federal Register Recent Federal Regulation Documents

Results 1 - 4 of 4

Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Antibody-Dependent Cellular Cytoxicity (ADCC)-Mediating Antibodies

Document Number: 2013-30367

Type: Notice

Date: 2013-12-20

Agency: Department of Defense, Department of the Army

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/762,543, entitled ``Antibody-Dependent Cellular Cytoxicity (ADCC)- Mediating Antibodies,'' filed on February 8, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

https://regulations.justia.com/regulations/fedreg/2013/12/20/2013-30367.html

Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Preoperative Recommendations Engine

Document Number: 2013-30359

Type: Notice

Date: 2013-12-20

Agency: Department of Defense, Department of the Army

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/849,910, entitled ``Preoperative Recommendations Engine,'' filed on January 14, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

https://regulations.justia.com/regulations/fedreg/2013/12/20/2013-30359.html

Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Therapeutic Peptides That Inhibit Rift Valley Fever Virus, Ebola Virus, Andes Virus and Vesicular Stomatitis Virus Infectivity, Compositions and Methods

Document Number: 2013-30357

Type: Notice

Date: 2013-12-20

Agency: Department of Defense, Department of the Army

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/733,966, entitled ``Therapeutic Peptides that Inhibit Rift Valley Fever Virus, Ebola Virus, Andes Virus and Vesicular Stomatitis Virus Infectivity, Compositions and Methods,'' filed on December 6, 2012. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

https://regulations.justia.com/regulations/fedreg/2013/12/20/2013-30357.html

Surplus Property Notice at a Military Installation Designated for Disposal: Pueblo Chemical Depot, Colorado

Document Number: 2013-30351

Type: Notice

Date: 2013-12-20

Agency: Department of Defense, Department of the Army

This notice provides information regarding the property that have been determined surplus to the United States needs in accordance with the Defense Authorization Amendments and Base Closure and Realignment Act, Public Law 100-526, as amended, and the 1988 Base Closure and Realignment Commission Report, as approved, and following screening with Federal agencies and Department of Defense components.

https://regulations.justia.com/regulations/fedreg/2013/12/20/2013-30351.html